» Articles » PMID: 27220278

Risk Allelic Load in Th2 and Th3 Cytokines Genes As Biomarker of Susceptibility to HPV-16 Positive Cervical Cancer: a Case Control Study

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2016 May 26
PMID 27220278
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Alterations in the host cellular immune response allow persistent infections with High-Risk Human Papillomavirus (HR-HPV) and development of premalignant cervical lesions and cervical cancer (CC). Variations of immunosuppressive cytokine levels in cervix are associated with the natural history of CC. To assess the potential role of genetic host immunity and cytokines serum levels in the risk of developing CC, we conducted a case-control study paired by age.

Methods: Peripheral blood samples from patients with CC (n = 200) and hospital controls (n = 200), were used to evaluate nine biallelic SNPs of six cytokine genes of the adaptive immune system by allelic discrimination and cytokines serum levels by ELISA.

Results: After analyzing the SNP association by multivariate logistic regression adjusted by age, CC history and smoking history, three Th2 cytokines (IL-4, IL-6 and IL-10) and one Th3 (TGFB1) cytokine were significantly associated with CC. Individuals with at least one copy of the following risk alleles: T of SNP (-590C > T IL-4), C of SNP (-573G > C IL-6), A of SNP (-592C > A IL-10), T of SNP (-819C > T IL-10) and T of SNP (-509C > T TGFB1), had an adjusted odds ratio (OR) of 2.08 (95 % CI 1.475-2.934, p = 0.0001), an OR of 1.70 (95 % CI 1.208-2.404, p = 0.002), an OR of 1.87 (95 % CI 1.332-2.630, p = 0.0001), an OR of 1.67 (95 % CI 1.192-2.353, p = 0.003) and an OR of 1.91 (95 % CI 1.354-2.701, p = 0.0001), respectively, for CC. The burden of carrying two or more of these risk alleles was found to have an additive effect on the risk of CC (p trend = 0.0001). Finally, the serum levels of Th2 and Th3 cytokines were higher in CC cases than the controls; whereas IFNG levels, a Th1 cytokine, were higher in controls than CC cases.

Conclusion: The significant associations of five SNPs with CC indicate that these polymorphisms are potential candidates for predicting the risk of development of CC, representing a risk allelic load for CC and can be used as a biomarker of susceptibility to this disease.

Citing Articles

High nasopharyngeal and serum IL-6 levels and the - 573G > C polymorphism (rs1800796) are linked with the risk of severe COVID-19 in a Mexican population: a case‒control study.

Torres-Poveda K, Bahena-Roman M, Contreras-Ochoa C, Lagunas-Martinez A, Bermudez-Morales V, Pando-Robles V BMC Infect Dis. 2025; 25(1):315.

PMID: 40045221 PMC: 11884130. DOI: 10.1186/s12879-025-10695-y.


Risk factors for the development of cervical cancer: analysis of the evidence.

Luvian-Morales J, Gutierrez-Enriquez S, Granados-Garcia V, Torres-Poveda K Front Oncol. 2024; 14:1378549.

PMID: 38846977 PMC: 11153748. DOI: 10.3389/fonc.2024.1378549.


Performance of an ancillary test for cervical cancer that measures miRNAs and cytokines in serum and cervical mucus.

Fujii T, Nishio E, Tsukamoto T, Kukimoto I, Iwata A Cancer Sci. 2024; 115(8):2795-2807.

PMID: 38749770 PMC: 11309926. DOI: 10.1111/cas.16214.


Interactions between vaginal local cytokine IL-2 and high-risk human papillomavirus infection with cervical intraepithelial neoplasia in a Chinese population-based study.

Zhu R, Wang W, Yang A, Zhao W, Wang W, Wang Z Front Cell Infect Microbiol. 2023; 13:1109741.

PMID: 37256111 PMC: 10225571. DOI: 10.3389/fcimb.2023.1109741.


Association of interleukin-10 , , and interleukin-6 polymorphisms with squamous cell carcinoma risk: A meta-analysis.

Wei Z, Su X, Hu Q, Huang Y, Li C, Huang X Open Life Sci. 2023; 18(1):20220580.

PMID: 37077342 PMC: 10106975. DOI: 10.1515/biol-2022-0580.


References
1.
Ramos-Flores C, Romero-Gutierrez T, Delgado-Enciso I, Maldonado G, Plascencia V, Vazquez-Vuelvas O . Polymorphisms in the genes related to angiogenesis are associated with uterine cervical cancer. Int J Gynecol Cancer. 2013; 23(7):1198-204. DOI: 10.1097/IGC.0b013e31829f4c6f. View

2.
Liu L, Yang X, Chen X, Kan T, Shen Y, Chen Z . Association between TNF-α polymorphisms and cervical cancer risk: a meta-analysis. Mol Biol Rep. 2011; 39(3):2683-8. DOI: 10.1007/s11033-011-1022-9. View

3.
Baena A, Leung J, Sullivan A, Landires I, Quinones-Berrocal J, Fraser P . TNF-alpha promoter single nucleotide polymorphisms are markers of human ancestry. Genes Immun. 2002; 3(8):482-7. DOI: 10.1038/sj.gene.6363898. View

4.
Kong S, Lee H, Eom H, Park W, Yun T, Kim H . Reference intervals for circulating angiogenic cytokines. Clin Chem Lab Med. 2008; 46(4):545-50. DOI: 10.1515/CCLM.2008.092. View

5.
Conesa-Zamora P . Immune responses against virus and tumor in cervical carcinogenesis: treatment strategies for avoiding the HPV-induced immune escape. Gynecol Oncol. 2013; 131(2):480-8. DOI: 10.1016/j.ygyno.2013.08.025. View